BCL2 (B-cell CLL/lymphoma 2)

In conclusion, 10 µM resveratrol supplementation improved sperm metabolic activity, enhanced oviduct binding capacity, and demonstrated antioxidant and anti-apoptotic effects. Thus, incorporating resveratrol into freezing extenders could be a promising strategy to improve the fertilizing capacity of equine sperm in artificial insemination programs.

Free-energy surface analyses revealed prominent protein conformations as well as ligand conformations that varied depending on the bound protein. Overall, insights from our computational analyses identified baicalin and licorice as promising multitarget inhibitors while also providing energetic and mechanistic understanding that can be leveraged in future rational drug design.

The inhibitory effect of DeGP-4 on MDA-MB-231 is better than cisplatin, and the inhibitory effect on BT-549 is comparable to cisplatin. DeGP-4 may suppress tumor cell migration and induced apoptosis by promoting reactive oxygen species (ROS) production and modulating the expression of key apoptotic proteins, including downregulation of Bcl-2 and upregulation of Bax and Caspase-3. Furthermore, in vivo experiments conducted the mouse tumor model, supported by histological and immunohistochemical analyses, confirmed the significant antitumor activity of DeGP-4.

This study highlights the multi-target and multi-pathway therapeutic potential of a seven-herb TCM formula against SAE and identifies potential bioactive compounds and therapeutic targets for further investigation.

Liposomes containing CAPE and vitamin D in a 1:1 molar ratio were more effective in inducing A375, B16F10 and HDF-1 cells death compared to their free mixture.

In addition, the expression of c-Myc and IRF9 in the liver, and c-Myc and BCL-2 in the spleen was modulated in a pregnancy-stage-specific manner. In summary, pregnancy modulated the expression of JAK/STAT members in maternal liver and spleen in a pregnancy-stage- and tissue-specific manner, which may contribute to the maternal immunotolerance and increases of spleen and liver sizes during gestation.

Shared differentially expressed genes between tumor and blood post-RT samples suggest that peripheral blood may partially capture systemic molecular responses after RT. These findings offer preliminary insights into the molecular landscape of canine oral melanoma and provide a hypothesis-generating basis for future validation of candidate molecular markers associated with RT response.

Overall, this integrative analysis suggests that TLXZF may exert its effects on HCC through a synergistic "multi-component-multi-target-multi-pathway" regulatory pattern, primarily involving oncogenic, inflammatory, and survival-related signaling networks. These findings are hypothesis-generating and provide an initial basis for the identification and screening of core bioactive components, key targets, and relevant pathways to support future experimental validation and clinical research.

The results show that the core targets of NAR for spinal cord injury include estrogen receptor 1, AKT serine/threonine kinase 1, B-cell lymphoma 2, PPARG, MAPK8, mechanistic target of rapamycin, protein kinase cAMP-activated catalytic subunit alpha, and HRas proto-oncogene, GTPase...In summary, this study systematically predicts the key targets and signaling pathways through which NAR may act in SCI, providing a theoretical basis for future mechanistic and translational research. However, because the findings are based on computational analyses alone, further in vitro and in vivo validation is required.

At all concentrations, luteolin significantly (1) promoted apoptosis and autophagy, (2) increased expression levels of Bax and cleaved caspase-3, (3) suppressed Bcl-2 expression, (4) enhanced autophagic vacuole formation, and (5) inhibited phosphorylation of PI3K, AKT, and mTOR pathways. Data suggest that luteolin inhibits proliferation of A549 cells by regulating apoptosis and autophagy.

Molecular docking studies supported the experimental findings. These combined results verify the potential of the synthesized derivatives as promising candidates for further investigation as biologically active anticancer agents.

While small-molecule inhibitors like venetoclax have shown success, issues with selectivity and resistance persist...These findings suggest that Traptamers function through a structure-driven mechanism, offering a programmable framework for targeting structurally challenging PPIs. This work establishes a computational proof-of-concept for repurposing RNA origami as selective, steric-based inhibitors in cancer therapy.